Zhengzhou, China

Jixuan Zhang

This inventor holds 4 USPTO granted patents and 6 published patent applications and 5 EPO patents. Top assignees: Henan Medinno Pharmaceutical Technology Co., Ltd., Henan Medinno Pharmaceutical Technology Co., Ltd., Shenzhen Kangsu Pharmaceutical Technology Co., Ltd.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jixuan Zhang. Retrieved from https://idiyas.com/inventor/jixuan-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023-2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Mind of Jixuan Zhang: A Pioneering Inventor in JAK Inhibitor Compounds

Introduction: Jixuan Zhang, an accomplished inventor based in Zhengzhou, China, holds two significant patents in the realm of pharmaceutical technology. With a focus on developing JAK inhibitors, his innovative compounds show promising applications in medicine. Zhang's contributions are vital in addressing JAK-related diseases, further establishing his role as a key figure in the pharmaceutical industry.

Latest Patents: Zhang's latest patents include breakthrough compounds identified as substituted pyrrolo[3,4-d]imidazoles, designed to serve as JAK inhibitors. The first patent outlines a class of JAK inhibitor compounds that may include various isomers or pharmaceutically acceptable salts. These compounds are under investigation for their applications in treating a range of medical conditions linked to JAK pathways. The second patent reiterates the significance of substituted pyrrolo[3,4-d]imidazoles as compounds that can be utilized in medical treatments, specifically focusing on their effectiveness against JAK-related diseases or disorders.

Career Highlights: Currently, Jixuan Zhang is associated with Henan Medinno Pharmaceutical Technology Co., Ltd., where he leverages his expertise in drug development. His commitment to innovation has led to vital advancements in pharmacological research, enhancing therapeutic options for patients affected by complex diseases.

Collaborations: Zhang's work is further enriched through collaboration with colleagues such as Hai Huang and Saisai Zhao. Their combined efforts foster an environment of creativity and shared knowledge, which is essential in driving their research outcomes and developing advanced therapeutic solutions.

Conclusion: Jixuan Zhang stands out as a notable inventor in the pharmaceutical domain, with two patented innovations that hold promise for future medical applications. His dedication to research and development not only showcases his innovative capabilities but also highlights his important contributions to advancing medical science in response to pressing health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…